Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines

IC Macdougall, AC Cooper - Nephrology dialysis transplantation, 2002 - academic.oup.com
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

IC Macdougall, AC Cooper - … : official publication of the …, 2002 - pubmed.ncbi.nlm.nih.gov
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

[引用][C] Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

LC MACDOUGALL… - Nephrology, dialysis …, 2002 - pascal-francis.inist.fr
Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

IC Macdougall, AC Cooper - Nephrology Dialysis Transplantation, 2002 - elibrary.ru
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

[PDF][PDF] Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

IC Macdougall, AC Cooper - Nephrol Dial Transplant, 2002 - scholar.archive.org
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines.

IC Macdougall, AC Cooper - Nephrology Dialysis …, 2002 - search.ebscohost.com
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

[PDF][PDF] Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

IC Macdougall, AC Cooper - Nephrol Dial Transplant, 2002 - researchgate.net
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.

IC Macdougall, AC Cooper - Nephrology, Dialysis, Transplantation …, 2002 - europepmc.org
Up to 10% of patients with renal disease receiving recombinant human erythropoietin
(rHuEPO) therapy show poor responsiveness to the drug. Even in patients who do respond …

[引用][C] Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

M IC - Nephrol Dial Transplant, 2002 - cir.nii.ac.jp
Erythropoietin resistance : the role of inflammation and pro-inflammatory cytokines | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[引用][C] Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines

IC Macdougall, AC Cooper - Nephrology Dialysis Transplantation, 2002 - cir.nii.ac.jp
Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …